COV2

COV2 is an investigational nasal vaccine developed by Rokote Laboratories Finland Oy, designed to protect against COVID-19. It is based on a serotype 5 adenoviral vector that delivers the genetic information for the SARS-CoV-2 spike protein. The vaccine aims to induce an immune response by presenting the spike protein to the immune system, thereby conferring protection against the virus. It is being evaluated for safety and immunogenicity at different dose levels and administration methods (nasal drops and nasal spray) in both booster and vaccine-naive subjects.

Other names

FINVAC COVID-19SARS-CoV-2 vaccine-Rokote Laboratories Finland Oy-COVID-19SARS-CoV2 vaccine-Rokote Laboratories Finland Oy-COVID-19SARS-CoV 2 vaccine-Rokote Laboratories Finland Oy-COVID-19Rokote Laboratories COVID-19 vaccine